By Professor Nada Hamad

Journal articles

Boyle S; Tobin JWD; Perram J; Hamad N; Gullapalli V; Barraclough A; Singaraveloo L; Han MH; Blennerhassett R; Nelson N; Johnston AM; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Jabbour A; Strasser SI; Chadban SJ; Brown C; Mollee P; Hapgood G, 2021, 'Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study from the Australasian Lymphoma Alliance', Hemasphere, 5, pp. E648, http://dx.doi.org/10.1097/HS9.0000000000000648

Farooq F; Cardonick E; Polushkina E; Ahmed S; Ramakrishnan P; Olszewski AJ; Yasin H; Hamad N; Lin Y; Edmonds J; Ciavolino L; Maggen C; Fruscio R; Gziri MM; Steffensen KD; Farooq U; Amant F; Sharon E; Yin T; Figg WD; Brandt J; Peer C; Vose JM; Evens AM, 2021, 'A Multi-Institution Analysis of Relapsed Lymphoma Occurring during Pregnancy Including Pharmacokinetics with Antenatal Checkpoint Inhibitor Therapy', Blood, 138, pp. 2457 - 2457, http://dx.doi.org/10.1182/blood-2021-149220

Dickinson M; Hamad N; Bryant CE; Borthakur G; Hosing C; Shook D; Tan J; Rajangam K; Liu H; Kennedy GA; McSweeney PA; Hill BT, 2021, 'A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies', Blood, 138, pp. 3868 - 3868, http://dx.doi.org/10.1182/blood-2021-146602

Abadir E; Othman J; Kwan J; Gottlieb DJ; Kennedy GA; Bajel A; Doocey R; Perera T; Watson A-M; Bardy PG; Greenwood M; Curtis DJ; Tran S; Moore J; Hamad N, 2021, 'Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry', Blood, 138, pp. 2929 - 2929, http://dx.doi.org/10.1182/blood-2021-149939

Mills G; Moore J; Cliff E; Fong CY; Mangalasseril S; Tiley C; Gilbertson M; Ku M; Bazargan A; Bryson M; Menzies Wojtowicz M; Sungala NP; Cunningham I; Tang C; Hamad N, 2021, 'Promising Real World Survival Data in Adult-Onset Langerhans Cell Histiocytosis: An Australasian Lymphoma Alliance 20 Year Retrospective Study', Blood, 138, pp. 2570 - 2570, http://dx.doi.org/10.1182/blood-2021-152131

Novitzky-Basso I; Linn SM; White J; Elemary M; Xenocostas A; Hamad N; Tan S; Culos S; Law A; Kim DDH, 2021, 'Propensity Score Matching Analysis Comparing Ruxolitinib Vs Historical Controls in 2 nd Line or Beyond Treatment for Chronic Gvhd after Therapy Failure', Blood, 138, pp. 1805 - 1805, http://dx.doi.org/10.1182/blood-2021-151683

Lim KJC; Di Ciaccio P; Hamad N; Polizzotto MN; Milliken S; Cochrane T; Goh Z; Shaw B; Perry E; Gilbertson M; Kermode W; Cheah CY; Latimer M; Ku M, 2021, 'Real-World Outcomes of Aggressive B-Cell Non-Hodgkin Lymphoma in People Living with HIV (PLWH) Treated in Australia: An Australasian Lymphoma Alliance Study', Blood, 138, pp. 1456 - 1456, http://dx.doi.org/10.1182/blood-2021-144817

Minson A; Hamad N; Yannakou CK; Wong SM; Butler JP; Seymour JF; Dickinson M, 2021, 'Trial in Progress: A Multicentre, Parallel Arm, Open-Label Trial of Frontline R-CHOP/Polatuzumab Vedotin-RCHP and Glofitamab in Younger Patients with Higher Risk Diffuse Large B Cell Lymphoma (COALITION)', Blood, 138, pp. 3571 - 3571, http://dx.doi.org/10.1182/blood-2021-147636

Cashman H; Mayson E; Kliman D; Kesby J; Bell J; Vachalec S; Withers B; Lavee O; Milliken S; Moore J; Hamad N, 2021, 'Integrated electronic health record facilitates a safer and more efficient rural outreach haematology service', Internal Medicine Journal, 51, pp. 1869 - 1875, http://dx.doi.org/10.1111/imj.14973

R Di Ciaccio P; Emmett L; Hamad N, 2021, 'Qualitative study of nuclear medicine physicians' perceptions of positron emission tomography/computed tomography in pregnant patients with cancer', Internal Medicine Journal, 51, pp. 1722 - 1726, http://dx.doi.org/10.1111/imj.15515

Di Ciaccio PR; Mills G; Tang C; Hamad N, 2021, 'Managing haematological malignancies in pregnant women', Lancet Haematology, 8, pp. e623 - e624, http://dx.doi.org/10.1016/S2352-3026(21)00242-8

MacIntyre CR; Veness B; Berger D; Hamad N; Bari N, 2021, 'Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination – A risk–benefit analysis for people < 60 years in Australia', Vaccine, 39, pp. 4784 - 4787, http://dx.doi.org/10.1016/j.vaccine.2021.07.013

Hamad N; Ananda-Rajah M; Gilroy N; MacIntyre R; Gottlieb D; Ritchie D; Harrison S; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Milliken S; Bardy P; Larsen S; Ho PJ; Lai H; Bajel A; Butler J; Tiley C; D'Rozario J; Johnston A; Cochrane T; Mills T; Irving I; Pullon H; Purtill D, 2021, 'Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement', Internal Medicine Journal, 51, pp. 1321 - 1323, http://dx.doi.org/10.1111/imj.15263

Zeiser R; Polverelli N; Ram R; Hashmi SK; Chakraverty R; Middeke JM; Musso M; Giebel S; Uzay A; Langmuir P; Hollaender N; Gowda M; Stefanelli T; Lee SJ; Teshima T; Locatelli F, 2021, 'Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease', NEW ENGLAND JOURNAL OF MEDICINE, 385, pp. 228 - 238, http://dx.doi.org/10.1056/NEJMoa2033122

Scordo M; Wang TP; Ahn KW; Chen Y; Ahmed S; Awan FT; Beitinjaneh A; Chen A; Chow VA; Dholaria B; Epperla N; Farooq U; Ghosh N; Grover N; Hamad N; Hildebrandt GC; Holmberg L; Hong S; Inwards DJ; Jimenez-Jimenez A; Karmali R; Kenkre VP; Khimani F; Klyuchnikov E; Krem MM; Munshi PN; Nieto Y; Prestidge T; Ramakrishnan Geethakumari P; Rezvani AR; Riedell PA; Seo S; Shah NN; Solh M; Yared JA; Kharfan-Dabaja MA; Herrera A; Hamadani M; Sauter CS, 2021, 'Outcomes Associated with Thiotepa-Based Conditioning in Patients with Primary Central Nervous System Lymphoma after Autologous Hematopoietic Cell Transplant', JAMA Oncology, 7, pp. 993 - 1003, http://dx.doi.org/10.1001/jamaoncol.2021.1074

Tang C; Hamad N, 2021, 'Trials and tribulations: including women in cancer clinical research', Lancet Haematology, 8, pp. e477 - e478, http://dx.doi.org/10.1016/S2352-3026(21)00165-4

McCaughan G; Di Ciaccio P; Ananda-Rajah M; Gilroy N; MacIntyre R; Teh B; Weinkove R; Curnow J; Szer J; Enjeti AK; Ross DM; Mulligan S; Trotman J; Dickinson M; Quach H; Choi P; Polizzotto MN; Tam CS; Ho PJ; Ku M; Gregory G; Gangatharan S; Hapgood G; Cochrane T; Cheah C; Gibbs S; Wei A; Johnston A; Greenwood M; Prince HM; Latimer M; Berkahn L; Wight J; Armytage T; Hamad N, 2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247

Shah J; Shacham S; Kauffman M; Daniele P; Tomaras D; Tremblay G; Casasnovas RO; Maerevoet M; Zijlstra J; Follows G; P Vermaat JS; Kalakonda N; Goy AH; Choquet S; Den Neste EV; Hill BT; Thieblemont C; Cavallo F; La Cruz FD; Kuruvilla J; Hamad N; Bouabdallah R; Jäger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vasilakopoulos TP; Samal P; Nagy A; Ku M; Canales Albendea MÁ, 2021, 'Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma', Future Oncology, 17, pp. 1295 - 1310, http://dx.doi.org/10.2217/fon-2020-0946

Ross DM; Thomson C; Hamad N; Lane SW; Manos K; Grigg AP; Guo B; Erber WN; Scott A; Viiala N; Chee L; Latimer M; Tate C; Grove C; Perkins AC; Blombery P, 2021, 'Myeloid somatic mutation panel testing in myeloproliferative neoplasms', Pathology, 53, pp. 339 - 348, http://dx.doi.org/10.1016/j.pathol.2021.01.003

Lewis KL; Chin CK; Manos K; Casey J; Hamad N; Crawford J; Ho SJ; Issa S; Grigg A; Wood P; Gandhi MK; Do B; Nastoupil L; Hawkes EA; Cheah CY, 2021, 'Ibrutinib for central nervous system lymphoma: the Australasian Lymphoma Alliance/MD Anderson Cancer Center experience', British Journal of Haematology, 192, pp. 1049 - 1053, http://dx.doi.org/10.1111/bjh.16946

Connolly EA; Weickhardt AJ; Grimison PS; Heller G; Lewin JH; Liow ECH; Tung I; Tran B; Hill S; Walpole ET; McKenzie J; Kuchel A; Forgeson G; Tan ABT; Joshi A; Wickham A; Tan TH; Wang Y; Hamad N; Wong V, 2021, 'Australia and New Zealand (ANZ) outcomes of high-dose chemotherapy and stem cell transplantation for relapsed or refractory germ cell tumors (GCT) from 1999 to 2019: Multicenter registry-based study with ABMTRR.', JOURNAL OF CLINICAL ONCOLOGY, 39, http://dx.doi.org/10.1200/JCO.2021.39.6_suppl.382

Blennerhassett R; Purtill D; Hamad N, 2021, 'Letter to the Editor Regarding “Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia”', Transplantation and Cellular Therapy, 27, pp. 190 - 191, http://dx.doi.org/10.1016/j.jtct.2020.11.011

Di Ciaccio PR; Ritchie DS; Kennedy G; Milliken S; Purtill D; Gottlieb D; Perera T; Yeung DT; Larsen SR; Doocey RT; Greenwood M; Durrant S; Watson A-M; Butler A; Khot A; Curley C; Hamad N, 2021, 'Allogeneic Haematopoietic Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S394 - S395, http://dx.doi.org/10.1016/s2666-6367(21)00509-1

Di Ciaccio PR; Greenwood M; Kennedy G; Milliken S; Gottlieb D; Ritchie DS; Purtill D; Larsen SR; Spencer A; Perera T; Yeung DT; Durrant S; Butler A; Watson A-M; Lai HC; Doocey RT; Goodman HJ; Kerridge IH; Arthur C; Curley C; Stewart C; Micklethwaite K; Collins J; Cooney JP; Hamad N, 2021, 'Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S394 - S394, http://dx.doi.org/10.1016/s2666-6367(21)00508-x

Barge L; Tran S; Kennedy G; Ritchie DS; Gottlieb D; Milliken S; Spencer A; Purtill D; Perera T; Doocey RT; Larsen S; Butler A; Bardy P; Greenwood M; Durrant S; Curley C; Stewart C; Tam CS; Collins J; Balendran S; Di Ciaccio PR; Patil S; Han M-H; Hamad N, 2021, 'Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S133 - S135, http://dx.doi.org/10.1016/s2666-6367(21)00168-8

Lwin Y; Kennedy G; Gottlieb D; Kwan J; Ritchie D; Szer J; Milliken S; Browett P; Spencer A; Butler A; Bardy P; Greenwood M; Perera T; He S; McEwan A; Larsen S; Lai H; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era: A Retrospective Analysis from the Australasian Bone Marrow Transplant Recipient Registry', Biology of Blood and Marrow Transplantation, 26, pp. 2252 - 2261, http://dx.doi.org/10.1016/j.bbmt.2020.08.024

Wang J; Asch AS; Hamad N; Weickhardt A; Tomaszewska-Kiecana M; Dlugosz-Danecka M; Pylypenko H; Bahadur S; Ulahannan S; Koucheki J; Sun J; Li H; Chen F; Zhang X; Muth J; Kaminker P; Moore P; Sumrow BJ, 2020, 'A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma', Blood, 136, pp. 21 - 22, http://dx.doi.org/10.1182/blood-2020-139868

Minson A; Hamad N; Butler JP; Westerman DA; Ritchie D; Blombery P; Seymour JF; Tam CS; Dickinson M, 2020, 'A Phase II, Open-Label, Single Arm Trial to Assess the Efficacy and Safety of the Combination of Tisagenlecleucel and Ibrutinib in Mantle Cell Lymphoma (TARMAC)', Blood, 136, pp. 34 - 35, http://dx.doi.org/10.1182/blood-2020-138946

Moore J; Kwan J; Gottlieb D; Bajel A; Ritchie D; Yeung DT; Greenwood M; Purtill D; Tran S; Aarons D; Hamad N, 2020, 'A Prospective Haploidentical Peripheral Blood Stem Cell Transplant Study Using a Pre-Defined Conditioning Regimen Intensity Based on Age and the Hematopoietic Cell Transplantation Comorbidity Index- Anzhit 1: Encouraging Preliminary Survival Outcomes at One Year Follow up', Blood, 136, pp. 51 - 52, http://dx.doi.org/10.1182/blood-2020-142131

Cashman H; Mayson E; Kliman D; Vachalec S; Bell J; Milliken S; Moore J; Lavee O; Withers B; Hamad N, 2020, 'A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic', Blood, 136, pp. 5 - 5, http://dx.doi.org/10.1182/blood-2020-142209

Boyle S; Tobin JWD; Perram J; Hamad N; Barraclough A; Singaraveloo L; Han M-H; Blennerhassett R; Nelson NE; Johnston A; Talaulikar D; Karpe K; Bhattacharyya A; Cheah CY; Subramoniapillai E; Bokhari W; Lee C; Hawkes EA; Gullapalli V; Jabbour A; Strasser S; Chadban S; Brown C; Mollee P; Hapgood G, 2020, 'Management and Outcomes of Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder in the PET/CT Era: A Multicentre Study from the Australasian Lymphoma Alliance', Blood, 136, pp. 36 - 38, http://dx.doi.org/10.1182/blood-2020-140665

White J; Hamad N; Linn SM; Novitzky-Basso IN; Abduljalil O; Law A; Kim DDH, 2020, 'Multicenter, Retrospective Evaluation of Therapeutic Efficacy of Ruxolitinib for Chronic Gvhd Treatment', Blood, 136, pp. 45 - 47, http://dx.doi.org/10.1182/blood-2020-136164

Benajiba L; Carraway HE; Hamad N; Stein EM; Yannakou CK; Burroughs A; Harris S; Lane H; Nguyen DD; Stuart M; Vargas J; Puissant A; Stegmaier K; DiNardo CD, 2020, 'Trials in Progress: A Phase I Study to Evaluate the Safety and Pharmacokinetic Profiles of CB-5339 in Participants with Relapsed/Refractory Acute Myeloid Leukemia or Relapsed/Refractory Intermediate or High-Risk Myelodysplastic Syndrome', Blood, 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-140636

Paterson JA; Hwang A; Wong S; Sewell W; Joseph JE; Hamad N, 2020, 'Two Rare Cases of Severe Autoimmune Dyserythropoiesis without Any Underlying Haematological Malignancy or Autoimmune Disease', BLOOD, 136, http://dx.doi.org/10.1182/blood-2020-142281

Othman J; Greenwood M; Moore J; Larsen S; Watson AM; Arthur C; Bhattacharyya A; Bilmon I; Blyth E; Bryant A; Bryant C; Dunlop L; Fay K; Gibson J; Hamad N; Kerridge I; Kwan J; Ma D; Micklethwaite K; Milliken S; Panicker S; Stevenson W; Withers B; Wilcox L; Tran S; Gottlieb DJ, 2020, 'Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG', Biology of Blood and Marrow Transplantation, 26, pp. 1868 - 1875, http://dx.doi.org/10.1016/j.bbmt.2020.06.030

Purtill D; Antonenas V; Chiappini P; Tong D; O’Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai LJ; Greenwood M; Gottlieb DJ; Hamad N, 2020, 'Variable CD341 recovery of cryopreserved allogeneic HPC products: Transplant implications during the COVID-19 pandemic', Blood Advances, 4, pp. 4147 - 4150, http://dx.doi.org/10.1182/bloodadvances.2020002431

Kliman D; Nivison-Smith I; Gottlieb D; Hamad N; Kerridge I; Purtill D; Szer J; Ma D, 2020, 'Hematopoietic Stem Cell Transplant Recipients Surviving at Least 2 Years from Transplant Have Survival Rates Approaching Population Levels in the Modern Era of Transplantation', Biology of Blood and Marrow Transplantation, 26, pp. 1711 - 1718, http://dx.doi.org/10.1016/j.bbmt.2020.03.005

Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Manuel Sancho J; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin J-R; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B -cell lymphoma (SADAL): a single -arm, multinational, multicentre, open -label, phase 2 trial', LANCET HAEMATOLOGY, 7, pp. E509 - E522, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000544758900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kalakonda N; Maerevoet M; Cavallo F; Follows G; Goy A; Vermaat JSP; Casasnovas O; Hamad N; Zijlstra JM; Bakhshi S; Bouabdallah R; Choquet S; Gurion R; Hill B; Jaeger U; Sancho JM; Schuster M; Thieblemont C; De la Cruz F; Egyed M; Mishra S; Offner F; Vassilakopoulos TP; Warzocha K; McCarthy D; Ma X; Corona K; Saint-Martin JR; Chang H; Landesman Y; Joshi A; Wang H; Shah J; Shacham S; Kauffman M; Van Den Neste E; Canales MA, 2020, 'Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial', The Lancet Haematology, 7, pp. e511 - e522, http://dx.doi.org/10.1016/S2352-3026(20)30120-4

Di Ciaccio P; McCaughan G; Trotman J; Ho PJ; Cheah CY; Gangatharan S; Wight J; Ku M; Quach H; Gasiorowski R; Polizzotto MN; Prince HM; Mulligan S; Tam CS; Gregory G; Hapgood G; Spencer A; Dickinson M; Latimer M; Johnston A; Armytage T; Lee C; Cochrane T; Berkhahn L; Weinkove R; Doocey R; Harrison SJ; Webber N; Lee HP; Chapman S; Campbell BA; Gibbs SDJ; Hamad N, 2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859

Hamad N; Gottlieb D; Ritchie D; Kennedy G; Watson AM; Greenwood M; Doocey R; Perera T; Spencer A; Wong E; O'Brien T; Shaw P; Conyers R; Cole T; Milliken S; Bardy P; Larsen S; Lai H; Butler A; Fraser C; Bajel A; Butler J; Kerridge I; Purtill D, 2020, 'Bone Marrow Transplant Society of Australia and New Zealand COVID-19 consensus position statement', Internal Medicine Journal, 50, pp. 774 - 775, http://dx.doi.org/10.1111/imj.14867

Casasnovas RO; Daniele P; Tremblay G; Maerevoet M; Zijlstra J; Follows G; Vermaat JSP; Kalakonda N; Goy AH; Choquet S; Van Den Neste E; Hill BT; Thieblemont C; Cavallo F; de la Cruz F; Kuruvilla J; Hamad N; Bouabdallah R; Jäger U; Caimi P; Gurion R; Warzocha K; Bakhshi S; Sancho JM; Schuster M; Egyed M; Offner F; Vasilakopoulos T; Samal P; Nagy A; Ku M; Canales Albendea MÁ, 2020, 'PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor', Value in Health, 23, pp. S479 - S480, http://dx.doi.org/10.1016/j.jval.2020.08.462

Gerstl B; Sullivan E; Koch J; Wand H; Ives A; Mitchell R; Hamad N; Anazodo A, 2019, 'Reproductive outcomes following a stem cell transplant for a haematological malignancy in female cancer survivors: a systematic review and meta-analysis', Supportive Care in Cancer, 27, pp. 4451 - 4460, http://dx.doi.org/10.1007/s00520-019-05020-8

Lwin Y; He SZ-X; Spencer A; Purtill D; Mcewan A; Browett P; Butler A; Carter J; Bardy PG; Kennedy GA; Szer J; Ritchie D; Greenwood M; Larsen SR; Milliken S; Lai HC; Gottlieb D; Kwan J; Aarons D; Tran S; Hamad N, 2019, 'An Update of Australasian Trends in Allogeneic Stem Cell Transplantation for Myelofibrosis in the Molecular Era', BLOOD, 134, http://dx.doi.org/10.1182/blood-2019-126547

Park JH; Woo YM; Youm EM; Hamad N; Won HH; Naka K; Park EJ; Park JH; Kim HJ; Kim SH; Kim HJ; Ahn JS; Sohn SK; Moon JH; Jung CW; Park S; Lipton JH; Kimura S; Kim JW; Kim DH, 2019, 'HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia', Leukemia, 33, pp. 1439 - 1450, http://dx.doi.org/10.1038/s41375-018-0321-8

McCarthy R-L; McNamee N; Copelin B; Mills G; Wong S; Qiu MR; Earls P; Milliken S; Hamad N; Fay K; Lukeis R; Parker A; Moore J, 2019, 'A case series of langerhans cell histiocytosis with braf testing', Pathology, 51, pp. S92 - S92, http://dx.doi.org/10.1016/j.pathol.2018.12.243

Lewis KL; Dowling M; Bavishi K; Øvlisen AK; Hamad N; Choi P; Grigg A; P'Ng S; Filshie R; Ritchie DS; Bilmon I; Prince HM; Wolf M; Hertzberg M; Chuah H; El‐Galaly TC; Tam CS; Seymour JF; Cheah CY, 2019, 'CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMAS', Hematological Oncology, 37, pp. 535 - 537, http://dx.doi.org/10.1002/hon.221_2631

Poch Martell M; Hamad N; Shin E; Moon JH; Sohn SK; Uhm J; Michelis FV; Viswabandya A; Lipton JH; Messner HA; Kim DDH, 2017, 'Distinctive clinical characteristics and favorable outcomes in patients with large granular lymphocytosis after allo-HCT: 12-year follow-up data', European Journal of Haematology, 99, pp. 160 - 168, http://dx.doi.org/10.1111/ejh.12899

Moon JH; Hamad N; Sohn SK; Uhm J; Alam N; Gupta V; Lipton JH; Messner HA; Seftel M; Kuruvilla J; Kim DH, 2017, 'Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD', Annals of Hematology, 96, pp. 805 - 815, http://dx.doi.org/10.1007/s00277-017-2939-4

Zheng Q; Cao J; Hamad N; Kim HJ; Moon JH; Sohn SK; Jung CW; Lipton JH; Kim DDH, 2016, 'Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia', Journal of Translational Medicine, 14, pp. 82, http://dx.doi.org/10.1186/s12967-016-0837-5

Back to profile page